[Experimental study of cytoprotector effect of succinate-containing drugs on functional activity of liver].
Hepatoprotective effect of metabolism correctors has been studied on the model of experimental viral and toxic damage of the liver. Reamberin-based substrate compositions (cytoflavin and remaxol) exhibit antihypoxic effect, antioxidant activity, and cytoprotective action on the background of metabolic effect. Based on these results, the indicated preparations are recommended for clinical trials on acute and chronic viral liver disorders.